Category: St. Jude MedicalSyndicate content

Deflating the hype: Are we setting renal denervation up for disappointment?

November 1, 2013 by Arezu Sarvestani

Renal denervation has won a lot of praise as a potential solution for patients with resistant hypertension, but the excessive celebration of early clinical trial results may be setting everyone up for a major letdown and a harsh backlash. This week cardiologists at the Transcatheter Cardiovascular Therapeutics conference, including those involved with Medtronic's and Boston Scientific's clinical trials, warned of the dangers of exaggeration.

Deflating the hype: Are we setting renal denervation up for disappointment?

Renal denervation is still in its youth, but the limited clinical trials and lack of substantial confirmation hasn't curbed much of the hype for the technology as a means of treating patients with resistant hypertension.

TCT 2013: St. Jude Medical's Portico valve looks good at 30 days

October 29, 2013 by Arezu Sarvestani

Medical device titan St. Jude Medical continues gathering data on its Portico transcatheter aortic valve implantation system, releasing positive 30-day clinical trial results for 2 sizes of the device.

TCT 2013: St. Jude Medical's Portico valve looks good in new sizes

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TAVI: Germany's TCT goes head-to-head against Medtronic, St. Jude | MassDevice.com On Call

October 28, 2013 by Arezu Sarvestani

German medical device maker Transcatheter Technologies GmbH announces 1st-in-man implantation of its repositionable Trinity transcatheter aortic valve system, treading into territory already marked by medtech giants Medtronic and St. Jude Medical.

MassDevice On Call

MASSDEVICE ON CALL — Germany-based medical device company Transcatheter Technologies GmbH is making a bold stride into the transcatheter aortic valve implantation space, announcing 1st-in-man implantation of a device it says it intends to be the "the world's best repositionable heart valve."

TCT 2013: Device makers challenge Big Pharma for stroke prevention in afib patients

October 28, 2013 by Arezu Sarvestani

Panelists at this year's Transcatheter Cardiovascular Therapeutics symposium debate whether left atrial appendage occlusion device makers can compete against anti-coagulant drug makers, which have long held a coveted spot as the gold standard in stroke prevention for patients with atrial fibrillation.

TCT 2013: Device makers challenge Big Pharma for stroke prevention in afib patients

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TCT 2013: Docs trade barbs over LAA closure

October 28, 2013 by Arezu Sarvestani

Makers of atrial appendage occlusion devices sound off on whether the implants should continue to rely on hooks for anchoring, like St. Jude Medical's Amplatzer Amulet does, or find novel ways to keep the devices in place, the way some new device makers propose.

TCT 2013: Doctors trade barbs over LAA closure

St. Jude Medical's Amulet LAA occluder

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

USPTO declines St. Jude Medical's review request in patent in spat with Volcano

October 24, 2013 by Brad Perriello

The U.S. Patent & Trademark Office declines to review a patent in St. Jude Medical's long-running war with rival Volcano Corp.

USPTO declines St. Jude Medical's review request in patent in spat with Volcano
USPTO declines St. Jude Medical's review request in patent in spat with Volcano

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical wins FDA approval for Ilumien Optis device

October 22, 2013 by Brad Perriello

St. Jude Medical says the FDA approved its Ilumien Optis device, designed to measure blood flow and provide images of the heart during stenting procedures.

St. Jude Medical wins FDA approval for Ilumien Optis device

St. Jude Medical (NYSE:STJ) said today that the FDA granted pre-market approval for its next-generation Ilumien Optis device, which combines a pair of technologies to help guide physicians during stenting procedures.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp